A one-volume commentary and a two-volume set on African American Christianity highlight the mission and vision of ...

In a joint press release, Apollos announced that B&H ... The series backlist will remain with IVP Academic. Thomas Creedy, publishing director for Apollos, said they were "excited to excited ...

VIRGINIA BEACH, VA / ACCESSWIRE / October 22, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an ... or at www.spartancapital.com This press release shall not ...

Intravenous delivery of GTx-104 also has the potential to ... surface of the brain in the subarachnoid space between the brain and skull. Statements in this press release that are not statements of ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

Florida Sens. Marco Rubio (R) and Rick Scott (R) are questioning why the Biden administration hasn’t done more to leverage ...

About IV Choline Chloride IV Choline Chloride is an investigational, intravenous phospholipid substrate replacement ... Statements contained in this press release regarding matters that are not ...

Paul Ezra Rhoades was executed in 2011, and Richard Albert Leavitt was executed in 2012. ___ Associated Press reporter Gene Johnson contributed from Seattle.

Oct 24 (Reuters) - Medical device maker Baxter (BAX.N), opens new tab said on Thursday it expects to restart the highest-throughput intravenous solutions manufacturing line at a hurricane-hit ...

Abstract and Introduction Rationale for i.v. Antihypertensive Selection Clinical Pharmacology of i.v. Antihypertensives References There are potential concerns with the use of sodium nitroprusside ...

HSE’s press office is normally open from 9.00am to 5.30pm Monday to Friday. If you are a member of the media: please call 0151 922 1221 or email [email protected].